Question 1

What are the potential benefits of adding oral azacitidine to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma clinical trial (NCT03450343). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this combination compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma clinical trial (NCT03450343). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma clinical trial (NCT03450343). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma clinical trial (NCT03450343). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific tests or procedures I will need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma clinical trial (NCT03450343). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma clinical trial (NCT03450343). Contact the study team or your healthcare provider for specific answers.

What this study is about